Elusive biomarkers of sensitivity to combined PD1/CTLA4 blockade in metastatic castration-resistant prostate cancer

E. S. Antonarakis

doi:10.1016/j.annonc.2024.10.001

Elusive biomarkers of sensitivity to combined PD1/CTLA4 blockade in metastatic castration-resistant prostate cancer

E. S. Antonarakis

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1077-1079
Number of pages	3
Journal	Annals of Oncology
Volume	35
Issue number	12
DOIs	https://doi.org/10.1016/j.annonc.2024.10.001
State	Published - Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1016/j.annonc.2024.10.001

Find It

Find It at U of M Libraries

Cite this

@article{a5b4eb9c293049f4bd607daceee83e9b,

title = "Elusive biomarkers of sensitivity to combined PD1/CTLA4 blockade in metastatic castration-resistant prostate cancer",

author = "Antonarakis, \{E. S.\}",

year = "2024",

month = dec,

doi = "10.1016/j.annonc.2024.10.001",

language = "English (US)",

volume = "35",

pages = "1077--1079",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "12",

}

TY - JOUR

T1 - Elusive biomarkers of sensitivity to combined PD1/CTLA4 blockade in metastatic castration-resistant prostate cancer

AU - Antonarakis, E. S.

PY - 2024/12

Y1 - 2024/12

UR - https://www.scopus.com/pages/publications/85207535624

UR - https://www.scopus.com/pages/publications/85207535624#tab=citedBy

U2 - 10.1016/j.annonc.2024.10.001

DO - 10.1016/j.annonc.2024.10.001

M3 - Editorial

C2 - 39393776

AN - SCOPUS:85207535624

SN - 0923-7534

VL - 35

SP - 1077

EP - 1079

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Elusive biomarkers of sensitivity to combined PD1/CTLA4 blockade in metastatic castration-resistant prostate cancer

UN SDGs

Publisher link

Find It

Other files and links

Cite this